COMPARATIVE EFFICACY OF INTRAVENOUS MIDAZOLAM, MIDAZOLAM-KETAMINE, AND KETAMINE IN REDUCING THE PREVALENCE OF POST-SPINAL SHIVERING: A DOUBLE-BLIND CLINICAL TRIAL
Sangi, S., Alipour, N., Manouchehrian, N., Aligholizadeh, M. (2024). COMPARATIVE EFFICACY OF INTRAVENOUS MIDAZOLAM, MIDAZOLAM-KETAMINE, AND KETAMINE IN REDUCING THE PREVALENCE OF POST-SPINAL SHIVERING: A DOUBLE-BLIND CLINICAL TRIAL. EKB Journal Management System, 47(2), 1105-1117. doi: 10.21608/bfsa.2024.275448.2056
Siavash Sangi; Nasim Alipour; Nahid Manouchehrian; Maryam Aligholizadeh. "COMPARATIVE EFFICACY OF INTRAVENOUS MIDAZOLAM, MIDAZOLAM-KETAMINE, AND KETAMINE IN REDUCING THE PREVALENCE OF POST-SPINAL SHIVERING: A DOUBLE-BLIND CLINICAL TRIAL". EKB Journal Management System, 47, 2, 2024, 1105-1117. doi: 10.21608/bfsa.2024.275448.2056
Sangi, S., Alipour, N., Manouchehrian, N., Aligholizadeh, M. (2024). 'COMPARATIVE EFFICACY OF INTRAVENOUS MIDAZOLAM, MIDAZOLAM-KETAMINE, AND KETAMINE IN REDUCING THE PREVALENCE OF POST-SPINAL SHIVERING: A DOUBLE-BLIND CLINICAL TRIAL', EKB Journal Management System, 47(2), pp. 1105-1117. doi: 10.21608/bfsa.2024.275448.2056
Sangi, S., Alipour, N., Manouchehrian, N., Aligholizadeh, M. COMPARATIVE EFFICACY OF INTRAVENOUS MIDAZOLAM, MIDAZOLAM-KETAMINE, AND KETAMINE IN REDUCING THE PREVALENCE OF POST-SPINAL SHIVERING: A DOUBLE-BLIND CLINICAL TRIAL. EKB Journal Management System, 2024; 47(2): 1105-1117. doi: 10.21608/bfsa.2024.275448.2056